18 filings
8-K
VOR
Vor Biopharma Inc
10 Jun 24
Departure of Directors or Certain Officers
4:05pm
8-K
VOR
Vor Biopharma Inc
28 May 24
Departure of Directors or Certain Officers
4:54pm
8-K
VOR
Vor Biopharma Inc
2 May 24
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
4:07pm
8-K
VOR
Vor Biopharma Inc
5 Jan 24
Other Events
5:03pm
8-K
VOR
Vor Biopharma Inc
2 Nov 23
Multiple Clinical and Preclinical Presentations at ASH 2023
9:10am
8-K
6ogen6el onk771er
9 Jun 23
Regulation FD Disclosure
7:41am
8-K
xl68c8zlsyb6 1m4
26 May 23
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
e39a1 g52
14 Apr 23
Departure of Directors or Certain Officers
4:01pm
8-K
uqrt2qekd 0ht8oo9bx7
16 Feb 23
Regulation FD Disclosure
12:13pm
8-K
q9puh2ms3sg2ahic
23 Dec 22
Entry into a Material Definitive Agreement
4:07pm
8-K
3olajihw
14 Dec 22
Termination of a Material Definitive Agreement
4:32pm
8-K
rdf55t4 ru79a36m2yyl
7 Dec 22
Vor Bio Prices Underwritten Offering of Common Stock and Concurrent
4:59pm
8-K
q3fs1l5kq8di32o3jn
7 Dec 22
Regulation FD Disclosure
7:36am
8-K
gvx6e58
29 Nov 22
Regulation FD Disclosure
10:25am
8-K
6uscbmjw1a
17 Jun 22
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
22j98sauy
14 Apr 22
Departure of Directors or Certain Officers
4:01pm
8-K
w1d7vu1z
17 Jun 21
Entry into a Material Definitive Agreement
8:13am
8-K
5yr8mjc15yfkown8mdft
9 Feb 21
Vor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to
4:21pm
- Prev
- 1
- Next